Its important to remember shell that those on the trial have relapsed conditions. That is the SOC has already failed them. So the readout we have is of more significance that just looking at a comparison to SOC.
Hopefully the next trial will happen at a lower line of treatment. And with these results that could well happen. Then we would expect to see even better results.
All is progressing as it should.
PTX Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
